Skip to main content
Erschienen in: International Journal of Colorectal Disease 3/2011

01.03.2011 | Original Article

Nonselective matrix metalloproteinase but not tumor necrosis factor-α inhibition effectively preserves the early critical colon anastomotic integrity

verfasst von: Magnus S. Ågren, Thomas L. Andersen, Line Andersen, Christine Bruun Schiødt, Vikas Surve, Troels T. Andreassen, Juha Risteli, Lennart E. Franzén, Jean-Marie Delaissé, Anne-Marie Heegaard, Lars N. Jorgensen

Erschienen in: International Journal of Colorectal Disease | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Increased matrix metalloproteinase (MMP) activity has been implicated in the pathogenesis of colorectal anastomotic leakage. Tumor necrosis factor-α (TNF-α) induces MMPs and may influence anastomosis repair.

Methods

We assessed the efficacies of the nonselective hydroxamate MMP inhibitor GM6001, the selective hydroxamate MMP inhibitor AG3340 and a TNF-α antagonist with respect to anastomotic breaking strength of left-sided colon anastomoses in male Sprague–Dawley rats.

Results

Systemic GM6001 treatment effectively blocked MMP activity and maintained the initial breaking strength day 0 of the anastomoses when administered subcutaneously as daily depositions (100 mg/kg) or continuously (10 mg/kg/day). In contrast, the anastomotic biomechanic strength was lowered by 55% (p < 0.001) in vehicle-treated rats on postoperative day 3. GM6001 treatment increased breaking strength by 88% (p < 0.0005) compared with vehicle-treated rats day 3 and reduced (p = 0.003) the occurrence of spontaneous anastomotic dehiscence. Histologically, the anastomotic wound was narrower (p < 0.05) in the longitudinal direction in GM6001-treated animals whereas GM6001 had no significant effect on inflammatory cell infiltration or epithelialization. AG3340 (10 mg/kg) increased (p < 0.012) breaking strength by 47% compared with vehicle on day 3 but did not significantly prevent the reduction of the initial breaking strength on day 0. Although the increased TNF-α levels in the wound were attenuated, the anastomotic breaking strength was not improved (p = 0.62) by the TNF-α (10 mg/kg) inhibitor given systemically.

Conclusions

Pharmacological nonselective MMP inhibition ought to be explored as a prophylactic regimen to reduce anastomotic complications following colorectal resection. The involvement of TNF-α was insignificant in anastomotic wound healing in an experimental model.
Literatur
1.
Zurück zum Zitat Frye J, Bokey EL, Chapuis PH, Sinclair G, Dent OF (2009) Anastomotic leakage after resection of colorectal cancer generates prodigious use of hospital resources. Colorectal Dis 11:917–920CrossRefPubMed Frye J, Bokey EL, Chapuis PH, Sinclair G, Dent OF (2009) Anastomotic leakage after resection of colorectal cancer generates prodigious use of hospital resources. Colorectal Dis 11:917–920CrossRefPubMed
2.
Zurück zum Zitat Bertelsen CA, Andreasen AH, Jorgensen T, Harling H (2010) Anastomotic leakage after anterior resection for rectal cancer: risk factors. Colorectal Dis 12:37–43CrossRefPubMed Bertelsen CA, Andreasen AH, Jorgensen T, Harling H (2010) Anastomotic leakage after anterior resection for rectal cancer: risk factors. Colorectal Dis 12:37–43CrossRefPubMed
3.
Zurück zum Zitat Walker KG, Bell SW, Rickard MJ, Mehanna D, Dent OF, Chapuis PH, Bokey EL (2004) Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg 240:255–259CrossRefPubMed Walker KG, Bell SW, Rickard MJ, Mehanna D, Dent OF, Chapuis PH, Bokey EL (2004) Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg 240:255–259CrossRefPubMed
4.
Zurück zum Zitat Hendriks T, Mastboom WJ (1990) Healing of experimental intestinal anastomoses. Parameters for repair. Dis Colon Rectum 33:891–901CrossRefPubMed Hendriks T, Mastboom WJ (1990) Healing of experimental intestinal anastomoses. Parameters for repair. Dis Colon Rectum 33:891–901CrossRefPubMed
5.
Zurück zum Zitat Syk I, Ågren MS, Adawi D, Jeppsson B (2001) Inhibition of matrix metalloproteinases enhances breaking strength of colonic anastomoses in an experimental model. Br J Surg 88:228–234CrossRefPubMed Syk I, Ågren MS, Adawi D, Jeppsson B (2001) Inhibition of matrix metalloproteinases enhances breaking strength of colonic anastomoses in an experimental model. Br J Surg 88:228–234CrossRefPubMed
6.
Zurück zum Zitat Ågren MS, Andersen TL, Mirastschijski U, Syk I, Schiødt CB, Surve V, Lindebjerg J, Delaissé JM (2006) Action of matrix metalloproteinases at restricted sites in colon anastomosis repair: an immunohistochemical and biochemical study. Surgery 140:72–82CrossRefPubMed Ågren MS, Andersen TL, Mirastschijski U, Syk I, Schiødt CB, Surve V, Lindebjerg J, Delaissé JM (2006) Action of matrix metalloproteinases at restricted sites in colon anastomosis repair: an immunohistochemical and biochemical study. Surgery 140:72–82CrossRefPubMed
7.
Zurück zum Zitat Ågren MS, Andersen L, Heegaard AM, Jorgensen LN (2008) Effect of parenteral zinc sulfate on colon anastomosis repair in the rat. Int J Colorectal Dis 23:857–861CrossRefPubMed Ågren MS, Andersen L, Heegaard AM, Jorgensen LN (2008) Effect of parenteral zinc sulfate on colon anastomosis repair in the rat. Int J Colorectal Dis 23:857–861CrossRefPubMed
8.
Zurück zum Zitat Stumpf M, Klinge U, Wilms A, Zabrocki R, Rosch R, Junge K, Krones C, Schumpelick V (2005) Changes of the extracellular matrix as a risk factor for anastomotic leakage after large bowel surgery. Surgery 137:229–234CrossRefPubMed Stumpf M, Klinge U, Wilms A, Zabrocki R, Rosch R, Junge K, Krones C, Schumpelick V (2005) Changes of the extracellular matrix as a risk factor for anastomotic leakage after large bowel surgery. Surgery 137:229–234CrossRefPubMed
9.
Zurück zum Zitat Pasternak B, Matthiessen P, Jansson K, Andersson M, Aspenberg P (2010) Elevated intraperitoneal matrix metalloproteinases-8 and -9 in patients who develop anastomotic leakage after rectal cancer surgery: a pilot study. Colorectal Dis 12:e93–e98PubMed Pasternak B, Matthiessen P, Jansson K, Andersson M, Aspenberg P (2010) Elevated intraperitoneal matrix metalloproteinases-8 and -9 in patients who develop anastomotic leakage after rectal cancer surgery: a pilot study. Colorectal Dis 12:e93–e98PubMed
10.
Zurück zum Zitat Kiyama T, Onda M, Tokunaga A, Efron DT, Barbul A (2001) Effect of matrix metalloproteinase inhibition on colonic anastomotic healing in rats. J Gastrointest Surg 5:303–311CrossRefPubMed Kiyama T, Onda M, Tokunaga A, Efron DT, Barbul A (2001) Effect of matrix metalloproteinase inhibition on colonic anastomotic healing in rats. J Gastrointest Surg 5:303–311CrossRefPubMed
11.
Zurück zum Zitat Ågren MS, Jorgensen LN, Delaissé JM (2004) Matrix metalloproteinases and colon anastomosis repair: a new indication for pharmacological inhibition? Mini Rev Med Chem 4:769–778PubMed Ågren MS, Jorgensen LN, Delaissé JM (2004) Matrix metalloproteinases and colon anastomosis repair: a new indication for pharmacological inhibition? Mini Rev Med Chem 4:769–778PubMed
12.
Zurück zum Zitat de Hingh IH, Siemonsma MA, de Man BM, Lomme RM, Hendriks T (2002) The matrix metalloproteinase inhibitor BB-94 improves the strength of intestinal anastomoses in the rat. Int J Colorectal Dis 17:348–354CrossRefPubMed de Hingh IH, Siemonsma MA, de Man BM, Lomme RM, Hendriks T (2002) The matrix metalloproteinase inhibitor BB-94 improves the strength of intestinal anastomoses in the rat. Int J Colorectal Dis 17:348–354CrossRefPubMed
13.
Zurück zum Zitat Renkiewicz R, Qiu L, Lesch C, Sun X, Devalaraja R, Cody T, Kaldjian E, Welgus H, Baragi V (2003) Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats. Arthritis Rheum 48:1742–1749CrossRefPubMed Renkiewicz R, Qiu L, Lesch C, Sun X, Devalaraja R, Cody T, Kaldjian E, Welgus H, Baragi V (2003) Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats. Arthritis Rheum 48:1742–1749CrossRefPubMed
14.
Zurück zum Zitat Ishimura K, Moroguchi A, Okano K, Maeba T, Maeta H (2002) Local expression of tumor necrosis factor-alpha and interleukin-10 on wound healing of intestinal anastomosis during endotoxemia in mice. J Surg Res 108:91–97CrossRefPubMed Ishimura K, Moroguchi A, Okano K, Maeba T, Maeta H (2002) Local expression of tumor necrosis factor-alpha and interleukin-10 on wound healing of intestinal anastomosis during endotoxemia in mice. J Surg Res 108:91–97CrossRefPubMed
15.
Zurück zum Zitat Mirastschijski U, Johannesson K, Jeppsson B, Ågren MS (2005) Effect of a matrix metalloproteinase activity and TNF-alpha converting enzyme inhibitor on intra-abdominal adhesions. Eur Surg Res 37:68–75CrossRefPubMed Mirastschijski U, Johannesson K, Jeppsson B, Ågren MS (2005) Effect of a matrix metalloproteinase activity and TNF-alpha converting enzyme inhibitor on intra-abdominal adhesions. Eur Surg Res 37:68–75CrossRefPubMed
16.
Zurück zum Zitat Matsumoto H, Koga H, Iida M, Tarumi K, Fujita M, Haruma K (2006) Blockade of tumor necrosis factor-alpha-converting enzyme improves experimental small intestinal damage by decreasing matrix metalloproteinase-3 production in rats. Scand J Gastroenterol 41:1320–1329CrossRefPubMed Matsumoto H, Koga H, Iida M, Tarumi K, Fujita M, Haruma K (2006) Blockade of tumor necrosis factor-alpha-converting enzyme improves experimental small intestinal damage by decreasing matrix metalloproteinase-3 production in rats. Scand J Gastroenterol 41:1320–1329CrossRefPubMed
17.
Zurück zum Zitat de Meijer VE, Sverdlov DY, Popov Y, Le HD, Meisel JA, Nose V, Schuppan D, Puder M (2010) Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice. PLoS One 5:e11256CrossRefPubMed de Meijer VE, Sverdlov DY, Popov Y, Le HD, Meisel JA, Nose V, Schuppan D, Puder M (2010) Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice. PLoS One 5:e11256CrossRefPubMed
18.
Zurück zum Zitat Shalinsky DR, Brekken J, Zou H, McDermott CD, Forsyth P, Edwards D, Margosiak S, Bender S, Truitt G, Wood A, Varki NM, Appelt K (1999) Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann NY Acad Sci 878:236–270CrossRefPubMed Shalinsky DR, Brekken J, Zou H, McDermott CD, Forsyth P, Edwards D, Margosiak S, Bender S, Truitt G, Wood A, Varki NM, Appelt K (1999) Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann NY Acad Sci 878:236–270CrossRefPubMed
19.
Zurück zum Zitat Hande KR, Collier M, Paradiso L, Stuart-Smith J, Dixon M, Clendeninn N, Yeun G, Alberti D, Binger K, Wilding G (2004) Phase I and pharmacokinetic study of prinomastat, a matrix metalloprotease inhibitor. Clin Cancer Res 10:909–915CrossRefPubMed Hande KR, Collier M, Paradiso L, Stuart-Smith J, Dixon M, Clendeninn N, Yeun G, Alberti D, Binger K, Wilding G (2004) Phase I and pharmacokinetic study of prinomastat, a matrix metalloprotease inhibitor. Clin Cancer Res 10:909–915CrossRefPubMed
20.
Zurück zum Zitat Witte MB, Thornton FJ, Kiyama T, Efron DT, Schulz GS, Moldawer LL, Barbul A (1998) Metalloproteinase inhibitors and wound healing: a novel enhancer of wound strength. Surgery 124:464–470CrossRefPubMed Witte MB, Thornton FJ, Kiyama T, Efron DT, Schulz GS, Moldawer LL, Barbul A (1998) Metalloproteinase inhibitors and wound healing: a novel enhancer of wound strength. Surgery 124:464–470CrossRefPubMed
21.
Zurück zum Zitat Mirastschijski U, Haaksma CJ, Tomasek JJ, Ågren MS (2004) Matrix metalloproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds. Exp Cell Res 299:465–475CrossRefPubMed Mirastschijski U, Haaksma CJ, Tomasek JJ, Ågren MS (2004) Matrix metalloproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds. Exp Cell Res 299:465–475CrossRefPubMed
22.
Zurück zum Zitat Christensen H, Andreassen TT, Oxlund H (1992) Age-related alterations in the strength and collagen content of left colon in rats. Int J Colorectal Dis 7:85–88CrossRefPubMed Christensen H, Andreassen TT, Oxlund H (1992) Age-related alterations in the strength and collagen content of left colon in rats. Int J Colorectal Dis 7:85–88CrossRefPubMed
23.
Zurück zum Zitat Sassi ML, Eriksen H, Risteli L, Niemi S, Mansell J, Gowen M, Risteli J (2000) Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. Bone 26:367–373CrossRefPubMed Sassi ML, Eriksen H, Risteli L, Niemi S, Mansell J, Gowen M, Risteli J (2000) Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. Bone 26:367–373CrossRefPubMed
24.
Zurück zum Zitat Garnero P, Ferreras M, Karsdal MA, Nicamhlaoibh R, Risteli J, Borel O, Qvist P, Delmas PD, Foged NT, Delaissé JM (2003) The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res 18:859–867CrossRefPubMed Garnero P, Ferreras M, Karsdal MA, Nicamhlaoibh R, Risteli J, Borel O, Qvist P, Delmas PD, Foged NT, Delaissé JM (2003) The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res 18:859–867CrossRefPubMed
25.
Zurück zum Zitat Verhofstad MH, Lange WP, van der Laak JA, Verhofstad AA, Hendriks T (2001) Microscopic analysis of anastomotic healing in the intestine of normal and diabetic rats. Dis Colon Rectum 44:423–431CrossRefPubMed Verhofstad MH, Lange WP, van der Laak JA, Verhofstad AA, Hendriks T (2001) Microscopic analysis of anastomotic healing in the intestine of normal and diabetic rats. Dis Colon Rectum 44:423–431CrossRefPubMed
26.
Zurück zum Zitat Seifert WF, Wobbes T, Hendriks T (1996) Divergent patterns of matrix metalloproteinase activity during wound healing in ileum and colon of rats. Gut 39:114–119CrossRefPubMed Seifert WF, Wobbes T, Hendriks T (1996) Divergent patterns of matrix metalloproteinase activity during wound healing in ileum and colon of rats. Gut 39:114–119CrossRefPubMed
27.
Zurück zum Zitat Shaper KR, Savage FJ, Hembry RM, Boulos PB (2001) Regulation of matrix metalloproteinases in a model of colonic wound healing in a rabbit. Dis Colon Rectum 44:1857–1866CrossRefPubMed Shaper KR, Savage FJ, Hembry RM, Boulos PB (2001) Regulation of matrix metalloproteinases in a model of colonic wound healing in a rabbit. Dis Colon Rectum 44:1857–1866CrossRefPubMed
28.
Zurück zum Zitat Vaalamo M, Karjalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U (1998) Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol 152:1005–1014PubMed Vaalamo M, Karjalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U (1998) Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol 152:1005–1014PubMed
29.
Zurück zum Zitat Lokuta MA, Huttenlocher A (2005) TNF-alpha promotes a stop signal that inhibits neutrophil polarization and migration via a p38 MAPK pathway. J Leukoc Biol 78:210–219CrossRefPubMed Lokuta MA, Huttenlocher A (2005) TNF-alpha promotes a stop signal that inhibits neutrophil polarization and migration via a p38 MAPK pathway. J Leukoc Biol 78:210–219CrossRefPubMed
30.
Zurück zum Zitat Reunanen N, Li SP, Ahonen M, Foschi M, Han J, Kähäri VM (2002) Activation of p38 alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization. J Biol Chem 277:32360–32368CrossRefPubMed Reunanen N, Li SP, Ahonen M, Foschi M, Han J, Kähäri VM (2002) Activation of p38 alpha MAPK enhances collagenase-1 (matrix metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) expression by mRNA stabilization. J Biol Chem 277:32360–32368CrossRefPubMed
31.
Zurück zum Zitat Ipaktchi K, Mattar A, Niederbichler AD, Hoesel LM, Hemmila MR, Su GL, Remick DG, Wang SC, Arbabi S (2006) Topical p38 MAPK inhibition reduces dermal inflammation and epithelial apoptosis in burn wounds. Shock 26:201–209CrossRefPubMed Ipaktchi K, Mattar A, Niederbichler AD, Hoesel LM, Hemmila MR, Su GL, Remick DG, Wang SC, Arbabi S (2006) Topical p38 MAPK inhibition reduces dermal inflammation and epithelial apoptosis in burn wounds. Shock 26:201–209CrossRefPubMed
32.
Zurück zum Zitat Zubaidi A, Buie WD, Hart DA, Sigalet D (2010) Temporal expression of cytokines in rat cutaneous, fascial, and intestinal wounds: a comparative study. Dig Dis Sci 55:1581–1588CrossRefPubMed Zubaidi A, Buie WD, Hart DA, Sigalet D (2010) Temporal expression of cytokines in rat cutaneous, fascial, and intestinal wounds: a comparative study. Dig Dis Sci 55:1581–1588CrossRefPubMed
33.
Zurück zum Zitat Salmela MT, Pender SL, Karjalainen-Lindsberg ML, Puolakkainen P, Macdonald TT, Saarialho-Kere U (2004) Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing. Scand J Gastroenterol 39:1095–1104CrossRefPubMed Salmela MT, Pender SL, Karjalainen-Lindsberg ML, Puolakkainen P, Macdonald TT, Saarialho-Kere U (2004) Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing. Scand J Gastroenterol 39:1095–1104CrossRefPubMed
34.
Zurück zum Zitat Sachsenberg-Studer EM, Runne U, Wehrmann T, Wolter M, Kriener S, Engels K, Elshorst-Schmidt T, Kaufmann R, Borradori L (2001) Bullous colon lesions in a patient with bullous pemphigoid. Gastrointest Endosc 54:104–108CrossRefPubMed Sachsenberg-Studer EM, Runne U, Wehrmann T, Wolter M, Kriener S, Engels K, Elshorst-Schmidt T, Kaufmann R, Borradori L (2001) Bullous colon lesions in a patient with bullous pemphigoid. Gastrointest Endosc 54:104–108CrossRefPubMed
35.
Zurück zum Zitat Lund LR, Rømer J, Bugge TH, Nielsen BS, Frandsen TL, Degen JL, Stephens RW, Danø K (1999) Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J 18:4645–4656CrossRefPubMed Lund LR, Rømer J, Bugge TH, Nielsen BS, Frandsen TL, Degen JL, Stephens RW, Danø K (1999) Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J 18:4645–4656CrossRefPubMed
36.
Zurück zum Zitat Sinnamon MJ, Carter KJ, Fingleton B, Matrisian LM (2008) Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse. Int J Exp Pathol 89:466–475CrossRefPubMed Sinnamon MJ, Carter KJ, Fingleton B, Matrisian LM (2008) Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse. Int J Exp Pathol 89:466–475CrossRefPubMed
37.
Zurück zum Zitat Jensen SA, Vainer B, Bartels A, Brünner N, Sørensen JB (2010) Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells—associations with histopathology and patients outcome. Eur J Cancer 46:3233–3242CrossRefPubMed Jensen SA, Vainer B, Bartels A, Brünner N, Sørensen JB (2010) Expression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinases 1 (TIMP-1) by colorectal cancer cells and adjacent stroma cells—associations with histopathology and patients outcome. Eur J Cancer 46:3233–3242CrossRefPubMed
38.
Zurück zum Zitat Wagenaar-Miller RA, Gorden L, Matrisian LM (2004) Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev 23:119–135CrossRefPubMed Wagenaar-Miller RA, Gorden L, Matrisian LM (2004) Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev 23:119–135CrossRefPubMed
39.
Zurück zum Zitat Balcom JH, Keck T, Warshaw AL, Antoniu B, Lauwers GY, Fernandez-del Castillo C (2002) Perioperative matrix metalloproteinase inhibition therapy does not impair wound or anastomotic healing. J Gastrointest Surg 6:488–495CrossRefPubMed Balcom JH, Keck T, Warshaw AL, Antoniu B, Lauwers GY, Fernandez-del Castillo C (2002) Perioperative matrix metalloproteinase inhibition therapy does not impair wound or anastomotic healing. J Gastrointest Surg 6:488–495CrossRefPubMed
40.
Zurück zum Zitat Mirastschijski U, Impola U, Karsdal MA, Saarialho-Kere U, Ågren MS (2002) Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo. J Invest Dermatol 118:55–64CrossRefPubMed Mirastschijski U, Impola U, Karsdal MA, Saarialho-Kere U, Ågren MS (2002) Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo. J Invest Dermatol 118:55–64CrossRefPubMed
Metadaten
Titel
Nonselective matrix metalloproteinase but not tumor necrosis factor-α inhibition effectively preserves the early critical colon anastomotic integrity
verfasst von
Magnus S. Ågren
Thomas L. Andersen
Line Andersen
Christine Bruun Schiødt
Vikas Surve
Troels T. Andreassen
Juha Risteli
Lennart E. Franzén
Jean-Marie Delaissé
Anne-Marie Heegaard
Lars N. Jorgensen
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
International Journal of Colorectal Disease / Ausgabe 3/2011
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-010-1106-3

Weitere Artikel der Ausgabe 3/2011

International Journal of Colorectal Disease 3/2011 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.